BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1281061)

  • 1. Influence of calcitonin treatment on the osteocalcin concentration in the algodystrophy of bone.
    Sawicki A; Szulc P; Sobczyk T; Goliszewski J; Garnier P; Labuszewski R
    Clin Rheumatol; 1992 Sep; 11(3):346-50. PubMed ID: 1281061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A test for acute hypocalcemia using swine and salmon calcitonin].
    Fournié A; Valverde C; Tap G; Bazerque JJ; Ayrolles C
    Rev Rhum Mal Osteoartic; 1977 Feb; 44(2):91-8. PubMed ID: 847364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The calcitonin treatment of patients with algodystrophy].
    Solarova P; Kŭnev K
    Vutr Boles; 1990; 29(5):102-5. PubMed ID: 2080602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX; Li H
    Chin Med J (Engl); 2008 Jul; 121(14):1280-4. PubMed ID: 18713548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of nasal calcitonin in the treatment of post-traumatic algodystrophy.
    Bickerstaff DR; Kanis JA
    Br J Rheumatol; 1991 Aug; 30(4):291-4. PubMed ID: 1863827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone biomarkers in patients with chronic traumatic spinal cord injury.
    Sabour H; Norouzi Javidan A; Latifi S; Larijani B; Shidfar F; Vafa MR; Heshmat R; Emami Razavi H
    Spine J; 2014 Jul; 14(7):1132-8. PubMed ID: 24139865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender].
    Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
    Med Wieku Rozwoj; 2002; 6(3):257-65. PubMed ID: 12637780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
    Ofluoglu D; Karadag-Saygi E; Canbulat C; Gunduz OH; Kul-Panza E; Akyuz G
    Rheumatol Int; 2006 Feb; 26(4):288-91. PubMed ID: 15875189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sex and age on biochemical bone metabolism parameters.
    Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R
    Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in bone mass and bone turnover following distal forearm fracture.
    Ingle BM; Hay SM; Bottjer HM; Eastell R
    Osteoporos Int; 1999; 10(5):399-407. PubMed ID: 10591838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and urine markers of bone metabolism during the year after hip fracture.
    Yu-Yahiro JA; Michael RH; Dubin NH; Fox KM; Sachs M; Hawkes WG; Hebel JR; Zimmerman SI; Shapiro J; Magaziner J
    J Am Geriatr Soc; 2001 Jul; 49(7):877-83. PubMed ID: 11527478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
    Overgaard K; Hansen MA; Nielsen VA; Riis BJ; Christiansen C
    Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of algodystrophic syndromes with calcitonin].
    De Bastiani G; Nogarin L; Perusi M
    Minerva Med; 1978 May; 69(22):1485-94. PubMed ID: 79988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of nasal salmon calcitonin on calcium and bone metabolism.
    Thamsborg G; Skousgaard SG; Daugaard H; Schifter S; Kollerup G; Sørensen OH
    Calcif Tissue Int; 1993 Oct; 53(4):232-6. PubMed ID: 8275350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of intranasal calcitonin in the treatment of algodystrophy.
    Driessens M
    Br J Rheumatol; 1992 Aug; 31(8):567-9. PubMed ID: 1643458
    [No Abstract]   [Full Text] [Related]  

  • 18. Responses to salmon calcitonin in chronic renal failure: relation to histological and biochemical indices of bone turnover.
    Cundy T; Heynen G; Gaspar S; Earnshaw M; Bartlett M; Paton S; Kanis JA
    Eur J Clin Invest; 1981 Jun; 11(3):177-84. PubMed ID: 6791936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of menopause and hormone replacement therapy on bone alkaline phosphatase.
    Alexandersen P; Hassager C; Riis BJ
    Scand J Clin Lab Invest; 1995 Nov; 55(7):571-6. PubMed ID: 8633181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapeutic prospectives in reflex algodystrophy of the legs. Local intradermal calcitonin].
    Marini F; Veclani G
    Chir Ital; 1984 Oct; 36(5):864-71. PubMed ID: 6545144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.